STEVEN GIRGENTI - 03 Apr 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role: Director
Signature: /s/ Maria Zannes, as attorney-in-fact for Steven Girgenti
Issuer symbol: BIAF
Transactions as of: 03 Apr 2024
Net transactions value: +$323
Form type: 4
Filing time: 24 Apr 2024, 16:00:20 UTC
Previous filing: 29 Mar 2024
Next filing: 14 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIAF	Common Stock	Options Exercise	$75,224	+64,848	+6.5%	$1.16	1,056,606	03 Apr 2024	Direct
transaction	BIAF	Common Stock	Tax liability	$74,901	-33,438	-3.2%	$2.24	1,023,168	03 Apr 2024	Direct	F1
holding	BIAF	Common Stock						8,955	03 Apr 2024	By Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIAF	Stock Option (right to buy)	Options Exercise	$0	-64,848	-100%	$0.000000^*	0	03 Apr 2024	Common Stock	64,848	$1.16	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld to cover the exercise price of the options exercised.
F2	These shares are owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3	This option vested in 7 equal monthly installments beginning on April 28, 2014.